Search
WAVE Life Sciences Ltd
WVEAdd to Watchlist
6.160USD
+0.210+3.53%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.19BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of WAVE Life Sciences Ltd is 8.63, ranking 92 out of 389 in the Biotechnology & Medical Research industry. The average price target is 23.00, with a high of 36.00 and a low of 12.00.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
23.000
Target Price
+286.55%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
WAVE Life Sciences Ltd
WVE
16
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is WAVE Life Sciences Ltd's expected revenue for the next quarter?
WAVE Life Sciences Ltd's expected revenue is 7.05M.
What is WAVE Life Sciences Ltd's price target?
Analysts forecast that WAVE Life Sciences Ltd's price target is USD 23.00, with the highest forecast at USD 36.00 and the lowest forecast at USD 12.00.
How have WAVE Life Sciences LtdWVE's recent earnings per share performed?
The market expectation was USD -0.13, while WAVE Life Sciences LtdWVE's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.31.
What is the analyst rating for WAVE Life Sciences Ltd?
Based on the ratings of WAVE Life Sciences Ltd's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
